DOCS
Doximity Inc-Class A
NYSE · Health Care
$27.73
-5.59 (-16.78%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 533.73M | 450.71M | 1.31B | 1.36B | 1.17B |
| Net Income | 208.83M | 158.71M | 237.38M | 212.75M | 182.63M |
| EPS | — | — | — | — | — |
| Profit Margin | 39.1% | 37.2% | 18.1% | 15.6% | 15.7% |
| Rev Growth | +18.4% | +18.4% | +6.3% | -9.8% | +18.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 1.08B | 981.97M | 1.24B |
| Total Equity | — | — | 1.85B | 1.61B | 1.93B |
| D/E Ratio | — | — | 0.58 | 0.61 | 0.64 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 222.89M | 178.81M | 322.05M | 386.62M | 299.21M |
| Free Cash Flow | — | — | 170.09M | 180.43M | 155.60M |